INTRAVENOUS NURSING...N E W Z E A L A N D INTRAVENOUS NURSING INCORPORATED SOCIETY SINCE 2006 ISSUE 2 June 2018 EDITOR Ally Hale EDITORIAL Conference Conferences are one of the few

N E W Z E A L A N D

INTRAVENOUS NURSING

INCORPORATED SOCIETY SINCE 2006

ISSUE 2 June 2018

www.ivnnz.co.nz EDITOR Ally Hale

EDITORIAL Conference

Conferences are one of the few professional constants

in which health professionals can share their work and

network but economic uncertainty in healthcare has

resulted in a more discerning approach by health

organisations in their allocation of funding.

Nurses, being the largest professional group in

healthcare are strongly affected by cost reductions and

rely on the strength of conference content to build a

business case to attend. The programme is the greatest

challenge and often a balancing act with the potential

to make or break the event. With all good intents and

purpose, delegates should leave feeling energised,

motivated and bursting with ideas. If less than

captivated, they may doodle, tinker with phones or

daydream. What then is the recipe for success?

Previously you have told us that quality speakers,

original presentations, creative posters and technology

whets the appetite.

In Rotorua, we were unquestionably treated to some

very exciting research and innovative practice from

around the globe. The main ingredient, renowned

keynote speaker Dr. Vineet Chopra, charmed delegates

with his own brand of MAGIC. Diverse topics and quality

presentations further tantalised taste buds ensuring

there was something to appeal to everyone.

INNZ Inc. offer our congratulations to the following

winners: Best First-time Presenter- Jill Archer (Waikato),

Best-Presenter-Sam Keogh (Brisbane, Australia) and

Best Poster- Claire Rickard (Brisbane, Australia)

Cont. Page 3

MISSION STATEMENT A commitment to excellence in

Infusion Practice

IN THIS ISSUE Editorial

Ally Hale

President’s Annual Report

AGM - Kate Laidlow

Education

Jenny Heretini

Conference Report

Glosan Sadiasa-Manzhula

Conference Feedback

Ellen Jones

Departments

Editorial, IVNNZ Inc. Executive minutes,

Membership application form, IVNNZ Inc. Forum,

CVAD Workshop, Events.

IVNNZ Inc. is proud to be an

international affiliate of the

Infusion Nurse Society (INS)

of America

ISSUE 2 June 2018 Page 2 www.ivnnz.co.nz


Cont. from Page 1

sponsored by NZ Medical and Scientific, IVNNZ Inc. and

Reynard Health Supplies respectively.

Combined with cutting- edge technology, these

ingredients certainly packed a punch and delivered food

for thought. Add a sprinkle of humour, serve warmly to

friends and there you have it …...the proverbial icing on

the cake!

Reconnecting at conference is a reminder of what

motivates us – like-minded colleagues and friends sharing

the same passion and building strong connections. More

importantly is the promise of what can be accomplished

through working together to achieve excellence in clinical

practice and patient safety within the sphere of infusion

therapy.

Did we get the recipe right?

Your feedback told us we hit the brief!

IVNNZ Inc. wish to thank all the participants, without

whom, the success of the Rotorua conference would not

have been possible. We look forward to welcoming you

to the South Island in 2020. Venue and dates to be

confirmed.

IVNNZ Inc. gratefully acknowledges our Corporate

Sponsorship.

Without your continued support, advancements in

research and the wonderful arena to network and share

innovative practice would not be possible.

Ally Hale

IVNNZ Inc. Editor

Intravenous Nursing New Zealand Inc.

(IVNNZ Inc.)

Annual General Meeting (AGM)

Thursday 15th March 2018 – Rotorua

ANNUAL REPORT

Mission Statement: A commitment to excellence in

Infusion Therapy Practice with ongoing quality

improvements to patient care.

It is with great pleasure I present the President’s report at

the IVNNZ Inc. Annual General Meeting. This report

represents the activities of the IVNNZ Inc. Executive

Committee over the past 12 months. I would like to

acknowledge our executive committee members and

express my personal thanks to: Fiona Williams -Treasurer

and Conference Convener 2018, Ellen Jones-Secretary,

Lynette Lennox-Educator, Jenny Heretini-Second-in-

Charge (2IC) Educator, Catharine O’Hara-Editor and Ally

Hale-Private Sector Representative and 2018 Conference

Convener.

All work completed for IVNNZ Inc. is additional to

established busy employment commitments. The

executive’s collective vision, productivity, generous

personal commitment and great teamwork have further

shaped this organisation into the internationally

recognised society that it is. This does not happen without

each one of you. Thank you.

IVNNZ Inc. acknowledges the executive member’s

employers. Their support and encouragement for their

respective members has enabled us to continue the

important role of leading and developing this

organisation.

Incorporated Society Rules

In accordance with Incorporated Society Rules, IVNNZ Inc.

are required to hold an AGM. The 2017 Financial Report

was presented by Fiona Williams at the IVNNZ Inc. forum

held last year in Auckland. Future AGMs will continue to

coincide with the IVNNZ Inc. forums and or conferences.

President’s Annual Report


Membership

Retaining and recruiting membership continues to be an

area of focus for development.

Total Membership = 230

Individual membership = 211

Life members = 3

Honorary member = 1

Corporate members = 15

IVNNZ Inc. extends our gratitude to all corporate

members for their assistance with conferences, education

awards and individual funding. Corporate support

provides a forum for speakers to share knowledge,

augment education and, network with clinical colleagues.

Medical product specialists are a much- valued resource

providing support and exposure to the latest innovations

for clinical practice.

International Membership-Affiliated member of Infusion

Nurses Society (INS)

IVNNZ Inc. became an affiliated member of INS in 2010

and receives the following benefits:

Four complimentary INS memberships which include

complimentary subscriptions to the Journal of Infusion

Nursing (hard copy and electronic). Memberships are

exclusive to members of the executive committee.

One complimentary hard copy of Infusion Nursing

Standards of Practice and Policies and Procedure for

Infusion Nursing.

IVNNZ Inc. access to electronic articles from Journal of

Infusion Nursing

Global infusion nurses networking

Global Networking

IVNNZ Inc. would like to acknowledge the work and close

links being forged with the Alliance for Vascular Access,

Teaching and Research (AVATAR). This group work from

Griffith University, Brisbane, Australia and are led by

Professor Claire Rickard. Studies such as the One Million

Global (OMG) peripheral intravenous catheter study are

conducted by this group. A more detailed report and links

to the group are available on our web site.

It is hoped that we will forge a stronger academic

relationship with AVATAR in future years by becoming

research sites, the sharing of academic writings and the

development of Australasian guidelines for infusion

management.

Education

The CNS /Educator Forums provide an opportunity for

nurses working with advanced infusion therapy. Forums

are held annually providing an opportunity to network,

collectively brainstorm and develop strategies to improve

intravenous nursing nationwide. A special thank you to

Lynette Lennox whose leadership has facilitated in the

continuation of these educational infusion forums.

Central Venous Access Device (CVAD) Workshops Level 1

Education programmes require considerable preparation

and organisation. Four central venous access device

(CVAD) workshops were held in 2017. Members will note

that there has been a change in title and content to

reflect current thinking for CVAD management. The venue

has also been changed to be more cost effective. Thank

you to Lynette Lennox and Jenny Heretini for your

forward thinking in instigating these changes and for your

extensive time and contribution to these education

programmes.

The 2018 Education Calendar can be found on the IVNNZ

Inc. website.

Grants, Scholarships and Awards

1. Education, Study and Research Grant: Poonam Kumari

(Waitemata) took advantage of this grant, receiving

financial assistance to attend the 2017 Australian

Vascular Access Society (AVAS) conference held in

Perth, Australia.

2. IVNNZ Inc. Scholarship to attend an international

conference related to infusion therapy (established

2009): Successful recipients were Fiona Williams

(Tauranga) 2016 and Jenny Heretini (Waikato) 2017

who also attended the AVAS conference in Perth.

Presidents’ Award

Leads by example in their own clinical practice, advancing

education and generously share their knowledge with

others.

Tanya Clarke (Gold Coast Hospital, Australia)) received the

President’s Award at the 15th IVNNZ Inc. conference held

in Christchurch 2016.

Service Award

Works tirelessly behind the scenes to advance education

and show that extra commitment over and beyond what is

required.

Christine Beasley and Heather Hocking were the

recipients of the Service Award at the 15th IVNNZ Inc.

conference.


IVNNZ Inc. extends congratulations to all recipients.

Strategic Plan 2016 to 2022-available on website

IVNNZ Inc. strategies are to:

1. Promote quality and safe infusion therapy practices for

Aotearoa, New Zealand.

2. Provide guidance and direction in professional

development in infusion related practices.

3. Collaborate and partner with our members and global

organisations across the healthcare sector to promote

a consistent approach to infusion practices.

4. Advance innovative technology and research related to

infusion therapy practices.

5. Maintain the status of IVNNZ Inc. as an incorporated

society.

The Strategic Plan is available on the web site for further

viewing.

Infusion Therapy Standards of Practice

IVNNZ Inc. acknowledges the work of the Infusion Nurses

Society (INS) in the production of the 2016 edition of

Infusion Therapy Standards of Practice and remain

optimistic that the New Zealand(NZ) Directors of

Midwifery and Nursing Services (DOMNS) will endorse this

document to support practice within NZ once formally

approached.

Website

All executive members have a responsibility to maintain

and edit the website: www.ivnnz.co.nz Election to a

recently developed position on the executive team with a

designated responsibility for the website will occur at this

AGM.

Newsletter

IVNNZ Inc. Editor, Catharine O’Hara, has consistently

delivered a quarterly newsletter supported with regular

articles written by educator- Lynette Lennox. Many

members have also contributed articles. Thank you for

your contributions. I would encourage anyone to share

the good work they are doing toward excellence in

infusion management to submit an article. I would like to

acknowledge Catharine for her dedication and many

hours of editorial work.

Finally, I have enjoyed my second term as President of

IVNNZ Inc. and wish to thank all the committee for their

team work, support and advice over the previous four

years.

Kate Laidlow

President IVNNZ Inc.

Jenny Heretini, Clinical Nurse Specialist, Infusion & Related

Therapies employed at Waikato District Health Board and

elected representative of the IVNNZ Inc. Executive

committee, in the role of Educator.

Welcome from your New Educator

It is with great delight and excitement that I take up the

challenge and responsibility of the position of educator for

the next term for IVNNZ Inc. My nursing background

spans almost 30 years with most of those years employed

at Waikato District Health Board working in the Emergency

Department. While employed by Waikato, I acquired my

passion for education and held an educator role for a few

years. I have always adhered to best practice principles

and continue to emulate this and impart my knowledge in

my current role of Clinical Nurse Specialist- Infusion and

Related Therapies.

Over the last two years, I have eased myself into the role

of committee member and have brought to the table my

strengths, particularly contributing towards the weaving of

a cultural component into the IVNNZ Inc. Strategic Plan. In

addition, I have assisted Lynette Lennox (Past Educator)

with the planning and facilitation of the central venous

access device (CVAD) workshops in Auckland and observed

the way in which Lynette’s expertise, experience and

enthusiasm have impacted on each participant. I know I

have “big boots to fill” and will strive to produce high

quality, evidence-based education to our participants.

As IVNNZ Inc. are now endorsing the 2016 Infusion Nurses

Society (INS) Infusion Therapy Standards of Practice, I

thought what better way of becoming familiar with these

than to have a quiz?

If you would like to be included in the draw for a prize,

please email your answers to the 10 questions on the

following page to [email protected]

before June 30, 2018.

Please include your name and mailing address. All correct

entries will be eligible for the draw. The prize will be sent

via mail to your attached address and the winner will be

published in the next IVNNZ Inc.

Education

http://www.ivnnz.co.nz

mailto:[email protected]


The Quiz

1. Does the INS standards encourage validation of

continuing competency yearly, 3 yearly or on an

ongoing basis determined by your organisation

based on risks, incidences and concerns?

2. What are three factors to consider when

choosing the flush volume for Vascular Access

Devices (VAD):

type and size of catheter

size of patient

type of infusion being given

sex of patient

age of patient

3. What is the maximum number of attempts that

should be taken to insert a peripheral vascular

access device?

4. Can you use prefilled 0.9% Sodium Chloride

syringes to reconstitute intravenous medications?

5. Some patients may experience a disturbance in

taste and odour when prefilled 0.9% Sodium

Chloride flushes are used. What is this phenomenon

called?

6. When administering Parenteral Nutrition

without lipids what size micron filter should be

used?

7. You are required to administer antineoplastic

therapy to your patient. You are required to utilise

personal protective equipment (PPE). Choose from

the list below what is required:

double gloves

eye protection if splash a

possibility

gumboots

protective gown

closed system drug transfer

device is able

respiratory protection if

inhalation potential

hat

8. How often should a subcutaneous device access

site be rotated?

at every medication administration

every two days

every 7 days

every 7 days or as clinically indicated

9. An intraosseous access device should be left in

situ for no longer than how many hours?

10. When using adhesive engineered stabilisation

devices it is suggested that barrier solutions should

be used.

Can you use compound tincture

of benzoin as a barrier?

Yes/No? Please explain why or

why not.

All the best with doing some research to answer

these questions and I look forward to receiving your

entries by 30th June 2018.

Kind regards,

Jenny Heretini

Educator IVNNZ


The 16th Intravenous Nursing New Zealand Inc. (IVNNZ Inc.) 16th – 17th March 2018 Rotorua

Glosan Sadiasa-Manzhula is a registered nurse employed

at Mercy Hospital, Dunedin

Conference theme:

‘An Eruption of the Latest Innovative Practice In Infusion

Therapy’

I had the privilege, along with two other colleagues from

Mercy Hospital, to attend the IVNNZ Inc. two-day

conference held at the Rotorua Holiday Inn. Thank you

for the opportunity.

March 16 was filled with topics about peripherally and

centrally inserted central catheter lines which were

interesting despite my limited exposure to these, being a

Day Surgery Unit nurse. March 17 conference topics

included medication safety, intravenous (IV) flushing, and

responsible cannulation, all of which I hope to impart to

my colleagues as an IV Link Nurse Representative.

Below is a summary of each of the topics:

Are PICCs the CVC of the Future? Dr. Vineet Chopra

Comparing the risk and benefits of peripherally inserted

central catheters (PICCs) with other central venous

catheters (CVCs), the former had shown promising results

having less complications. Findings were based on “real-

world” data from the Michigan Hospital Medicine Safety

Consortium.

There was also evidence presented to support the claim

that the more lumens central or peripheral lines have-the

higher the risk of infection to the patient. Less number of

lumens means less occlusion and less deep vein

thrombus (DVT) rates. The speaker’s final verdict was: It

ALL depends on the patient, the device chosen and the

provider.

Ambiguity- How Guidelines Can Impede Best Practice

Vascular Access Device-related Bloodstream Infection

Prevention Prof. Cathryn Murphy

Infection prevention practices are assured by policies,

guidelines and regulations locally, nationally and globally.

New research and discoveries impact with new standards

for compliance. This speaker discussed challenges in the

uptake of policies due to factors such as staff behavior,

structural workplace variability, ongoing tolerance for

non-compliance and delays in embracing new

technologies. The more prescriptive the rules workers

have imposed on them, the less likely they are to comply.

Decontamination of the Needles Connector: an in vitro

study Julie Flynn

This study compared the decontaminating efficacy of 70%

isopropyl alcohol (IPA) wipe, a 2% chlorhexidine in 70%

IPA wipe and a 70% IPA impregnated cap on needleless

connectors subjected to bacterial and fungal

contamination. Result: the chlorhexidine in 70% IPA wipe

outperformed 70% IPA which had a 30 second

decontamination with a 30% reduction of organisms.

Researchers acknowledged refinement of the research

process needed to include a more defined

decontamination process.

Push-Pull techniques from taking blood from central lines Gill Archer A case study of a patient admitted to Waikato Hospital

with Acute Promyelocytic Leukemia (APML) was

presented. With deteriorating platelet, red blood and

white blood cell counts secondary to chemotherapy and

his pre-diagnosis condition, multiple blood transfusions

were recommended but conflicted with the patient’s

Jehovah Witness beliefs.

Unable to transfuse any blood, staff initiated a push-pull

technique. This technique avoids wasting or discarding any

blood during draws and utilising sodium chloride to pull

out blood from central lines and push it back again until

the blood drawn is suitable for laboratory testing. Trialed

only for this patient, following its success, the technique

was later used for all hematology patients in the ward.

Nursing staff had managed to save a significant amount of

blood for the patient. The standard procedure previously

used for taking bloods meant a minimum 5mLof blood

Conference Report


was discarded each draw, at least twice daily, from

peripherally inserted central catheters. The patient is

recovering well and was discharged from hospital. It was

good to note that staff had discussed the situation with

the patient and researched to understand the significance

of his major decision to refuse blood transfusions.

Dissociation from the Jehovah Witness group and shunned

by its members may have resulted had the patient

accepted the blood.

IV administration set dwelling time presented by Claire

Rickard

The objective of the study was to compare 4- and 7- day

administration (Infusion) set replacement for the

prevention of infection in central venous and peripheral

arterial catheters. Result: IV administration set

replacement after 7 days was non-inferior to 4 days and

cost-effective. Overall participants = 2941.

Effective PICC securement Elizabeth Culverwell

Canterbury District Health Board (CDHB) introduced a

subcutaneous sutureless securement device following a

four-month trial in 2015, acknowledging that PICC

securement is key to prevent malposition, blood stream

infection, thrombosis, fatal events and re-insertion.

Equally important was the mentoring and coaching in the

use of the introduced method which enhanced staff

engagement, confidence and commitment and eventually

helped in the realization of the programme. High

compliance resulted in desired outcomes such as

improved capability and skill, a display of fiscal

responsibility and markedly reduced PICC migration and

blood stream infection (BSI).

CoolSense® by Rachel Wilson

The Children’s Haematology and Oncology Centre (CHOC)

at Christchurch Hospital trialed an alternative to topical

anaesthetic creams to numb the site of injection for

painful procedures using the CoolSense® pain numbing

applicator.

A qualitative assessment tool (8-Question Survey Monkey)

captured family experiences with the product and its

efficacy over topical anaesthetic creams.

Results: 87% of respondents answered they would

recommend CoolSense® to other patients.

Benefits:

Reduced waiting time

Reduced pain

Reduced cost -CoolSense® device costs $160 and comes

with alcohol cartridge that yields 350+ uses. Emla cream

costs $9 per 5gm single use tube. Potential savings=

$8780 per 1000+ applications.

Medication Safety Continuous Quality Improvement

Catharine O’Hara

Data was collected and analysed from 158 Electronic

Infusion Devices (EID) installed with medication safety

software, which defines dosing limits for the drugs

commonly used within Mid Central District Health Board

(DHB).

Results:

The top 15 drugs and fluids most frequently causing

alerts were identified

Trends demonstrated when the most frequent number

of alerts occurred in a 24 hour time frame

Findings helped make decisions on amendments of the

drug datasets and enabled MidCentral DHB to make

necessary changes to the five clinical profiles ensuring

compliance of medication administration and the

promotion of patient safety.

Pumping in Perth Jenny Heretini

Jenny Heretini, Clinical Nurse Specialist, shared her

experience of attending the 2017 Australian Vascular

Access Society (AVAS) 2nd Scientific Meeting coupled with

the 2016 World Congress on Vascular Access (WoCoVA)

conference highlights.

Medication Safety Then & Now Carolyn Wilson

This is a presentation of the review on the progress made

in reducing adverse drug events in New Zealand since year

2000.

Carolyn previously presented the paper ‘Medication Errors-

the Silent Epidemic’ in 2001, a time when the extent and

severity of harm caused by adverse drug events was still

largely hidden. The years 1999 and 2000 brought to light

the epidemic as talked about on the release of ‘To err is

human. Building a safer health system’ and a full issue of

the British Medical Journal was dedicated to medical error

accordingly. With ongoing progress reviews, themes and

trends in health care settings can now be identified and

future directions discussed.

OPIVA (Out Patient IV Antibiotics) Bev Hopper

This widely accepted, effective, time-tested and safe

therapeutic option in providing treatment for infections

for selected patients in the community setting paved the

way for Aged Residential Care (ARC) facilities to be

involved with the management of patients requiring IV


antibiotic administration instead of keeping them as

inpatients in a hospital setting. E-learning packages,

practical workshops for central line management and IV

antibiotic administration, policies, and ongoing support

are provided to ARC nurses and participating community

workers.

IV Flushing & Patency: Not As Simple As You Think

Presenter: Samantha Keogh

Don’t rush your flush- NO MORE THAN 1ML/SEC

Regular flushing and locking aims to prevent occlusion

and infection by minimising the build-up of biofilm or

other substances inside the catheter lumen. Several IV

flush studies had previously highlighted inconsistences

with flushing and infusion practices and also adherence

to aseptic non-touch technique (ANTT) principles. This

presentation showed the impact of IV flushing and

infusions on vascular access devices (VAD) which were

digitally recorded for good visualisation. Varied flushing

speeds were tested and recorded using laminar versus

pulsatile flow. Turbulent flows (140cm/sec) caused minor

tip flexion of the IV catheter tip in the vessel lumen.

Ejection velocity of >200cm/sec demonstrated IV

catheter tip flexion. It is worth noting, that the aim of a

good IV maintenance practice is to minimize secondary

(post IV insertion) injury and inflammation. Catheter tip

friction to vessel surface has implications on vessel health

and outcome of VAD maintenance. Additionally, good

judgment on catheter size selection matters.

INS Recommendations:

Assessment of catheter and site

Aspiration of blood

Pre/post drug administration

At least Q24H flushing if not in use

Use of manufacturer prepared pre-filled syringe

Volume at least x2 the length and diameter of the

catheter

Use of gentle, pulsatile technique(except post-blood

transfusion and some drugs)

Expected outcomes of quality IV insertion & care:

Insertion of the right device, by the right person, the

first time

The device is maintained without complications for the

duration of the treatment until it is removed

PRICT (Practice Responsible Intravenous Cannulation

Today) Project Lynne Gledstone-Brown

‘Just in case’ cannulas create opportunities for unjustified

patient risk or harm. Although often an essential

procedure, the benefits must be weighed against the

risks, and necessity against convenience.

Research shows 50% of patients presenting to emergency

departments who receive IV cannulations don’t actually

need them. Wellington Emergency Department sought to

embark on a patient centered quality initiative to

encourage critical thinking and assessment to improve

the cannulation care they provide.

PRICT implementation involved:

Re-arranging of cannulas and venipuncture consumables

Identifying champions

Stickers

Introduction of guidelines for peripheral intravenous

cannula (PIVC) insertion

Regular follow-up audits

Results:

30% reduction in PIVC insertion

17% increase in venipuncture

Huge cultural shift within the department as a whole

$5889.50 savings per month

Reduced risk of infection

Risk of bloodstreams and venous infections in 12623

peripheral IV catheters in Australia Claire Rickard

The objective of the study was to quantify risk of primary

bloodstream and local infections with PIVCs and to assess

relationship to dwell time.

Result: There was no increase in BSI risk with dwell time.

Infections did occur from Day 2 to Day 7 in 1-19 days

dwell time but at a very low rate and no trend was

detected over time. Complex patients were most at risk.

Each day of dwell is a risk, but later days are not anymore

risky than earlier days.

MAGIC (Michigan Appropriateness Guide for

Intravenous Catheters Dr. Vineet Chopra

MAGIC is an evidenced-based tool which originated in

Michigan to provide criteria for the appropriate use of a

PICC.


All the presenters did an awesome job. I couldn’t be any

more grateful to be part of Intravenous Nursing New

Zealand. As part of the IV Link Nurse team in Mercy

Hospital, I take pride in my role.

The venue, food, and hosts were outstanding and I’m sure

IVNNZ Inc. will consider suggestions from participants. In

particular, to ensure that abstracts are showcased and

evaluated according to category. For example: funded

research versus local initiatives.

Delegates from Mercy Hospital (Glosan, second from the

right)

It was also a cultural enrichment for me as I was able to

visit the “Living Maori Village” just behind the venue and

learned so much.

Update on Change to PHARMAC Bulk Fluids In March 2018, PHARMAC announced the decision about national procurement activity for intravenous (IV) fluid bags and a range of irrigation solutions, collectively referred to as bulk fluids.

We know these changes will be of interest to District Health Board (DHB) IV nurses, and wanted to update you on the following activities that will be undertaken to support DHBs with these changes.

We have identified and communicated with key staff within each DHB, from procurement, pharmacy or both, who will be primarily managing the change in the first instance.

A number of resources are being developed that will include;

A summary of the product changes

Product information including photos of the new products

Schedule listing and Hospital Supply Status (HSS) dates for each new product

Supplier and product codes

Supplier contact details.

Key messages for staff about the change including recycling messages

The resources will be sent to these key staff no later than Monday 21 May 2018 to use and/or to distribute to other relevant DHB staff. The Pharmaceutical Schedule listing dates for the first of the products with new suppliers start from 1 June 2018.

Two suppliers – B. Braun and Fresenius Kabi supply the majority of IV fluids and irrigation solutions that will change from the current supplier. They intend to provide training to DHB staff about how to use their products. If you are not aware of training occurring in your DHB and would like training please contact:

Fresenius Kabi: Susan O’Connell [email protected] B. Braun (NZ) 0800 227 286.

If you have any questions relating to

PHARMAC bulk fluids

implementation activities please

contact the PHARMAC

implementation leads for this

activity, Angela Cathro

[email protected] or

Bronwyn Locke

I

https://www.pharmac.govt.nz/news/notification-2018-03-09-hospital-bulk-fluids/




An Eruption of the Latest Innovative

Practices in Infusion Therapy: 2018 Conference Feedback Report

Collated by Ellen Jones, IVNNZ Inc. Secretary

A total of 68 delegates completed the Conference Feedback and Evaluation Questionnaire forms.

Question 1. How did you hear about this conference? Delegates had the opportunity to tick more than one box for this question.

This year, the website and word of mouth were the two most popular methods for conference advertising. Delegates who ticked other were informed of the conference by either their manager or through a workplace meeting. The flyer and the email methods remain popular and accounted for 25% each. A conclusion can be drawn that the conference was well advertised and these four methods should continue to be used.

Question 2. Please specify your reason for attending this conference Most delegates ticked more than one box. The most popular reason for attending the conference was for their own professional development.

Question 3: Please indicate your overall satisfaction with content and delivery This question allowed the delegates to score their level of satisfaction from very satisfied to very dissatisfied. The keynote speakers especially Dr., Vineet Chopra was an obvious success.

Question 4. I can put what I learned to immediate use?

Question 5. Please indicate your overall satisfaction with this conference Even though many verbal and written comments were made about the catering standard the overall scoring was between neutral to somewhat satisfied.

Question 6. What were the strengths of the conference? I have collated the top 10 answers 1.Keynote speakers 2.Invited speakers especially Karen Winterbourne 3.Networking 4.Wide/varied range of topics covered 5.Knowledge and passion of speakers 6.Well organised conference 7.Patient experience 8.Trade displays 9.New data 10.Informative and up-to-date

Question 7. What were the weaknesses of the conference? 1.Cold venue 2.Uncomfortable chairs 3.Poor acoustics 4.Light behind speakers too bright 5.Posters too isolated

Question 8. Would you recommend this conference to others? Question 9. What speakers or topics would interest you for the IVNNZ Inc. Conference in 2018? I have collated the top 5 answers 1.The use of ultrasound guided insertion 2.Consider a different stream for scientific presenters in regards to the awards 3.Would be good to have two streams for best presenter. Having a scientific stream and a clinical stream 4.Ports/power ports 5. Have practical workstations

Conference Feedback






IVNNZ Inc. Executive Committee minutes: available on the website for members

IVNNZ Inc. Education, Study and Research Grants

details for members are available on the website.

Meetings

IVNNZ INC. EXECUTIVE COMMITTEE MEETINGS

When 4 May 2018

Where Wellington

When 20-21 July 2018

Where Te Awamutu

When 2 November 2018

Where Wellington

National

Educational Events

CVAD WORKSHOP

When 10 August 2018

Where Auckland

When 9 November 2018

Where Auckland

IVNNZ Inc. Welcomes New Members

Membership application form - IVNNZ

Inc. invites you to join

If you have a passion for Infusion Therapy and

your practice is important to you, we need

you to be part of this organisation.

Your membership application can be

completed online or download an application

form and send by e-mail.

The Membership application process and

rules are available via the website:

http://www.ivnnz.co.nz/membership-login/New-Members

http://www.ivnnz.co.nz/about-ivnnz-inc./Rules-of-IVNNZ-Inc

International

WOCOVA 5TH CONFERENCE

When 20-22 June 2018

Where Copenhagen Denamrk

AVA 2018 ANNUAL SCIENTIFIC MEETING https://www.eventscribe.com/2018/AVA

When 15-18 September 2018

Where Colubus Convention Center, Clumbus, Ohio USA

INS ANNUAL CONVENTIONS AND INDUSTRIAL EXHIBITIONS https://www.ins1.org/default.aspx

When May 2019

Where USA (Venue TBC)

IVNNZ Inc. encourages

members to apply for

educational assistance in the

form of Scholarship or Grants.

You are eligible to apply for a

Grant every three years to

attend conference.

The successful applicant receives up to $3000 and

$5000 to attend Australasian and European/

American conferences respectively.

http://www.ivnnz.co.nz/files/file/7606/IVNNZ%20Inc.%20Grant%20Application.doc\zulu\users$\eriloc\My%20Documents\AUT

mailto:mailto:[email protected]







https://www.ins1.org/default.aspx


Covering all aspects of Anatomy, Insertion,

Care, Maintenance, Complications, and

Clinical Workstations

Friday 25th May

Friday 10th August

Friday 9th November

0830-1530hrs

Holiday Inn

2 Ascot Road Airport Oaks

Auckland

$50 IVNNZ members

$100 Non members

Morning tea/lunch provided

Please register online

http://www.ivnnz.co.nz/page/Workshops

20

18 I

VN

NZ

Inc.

CV

AD

Wo

rksh

op

Payment required at booking to secure place on workshop

COPY DEADLINE

We welcome your input into the newsletter. Please forward articles, correspondence or ideas to the

Editor prior to 20th August 2018.

Any comments made in the newsletter are not necessarily the view of the IVNNZ Inc. Executive.

Product Information is supplied by the manufacturers and is published in this newsletter to inform

readers. No endorsement is implied or intended by IVNNZ Inc.

http://www.ivnnz.co.nz/page/Workshops



IVNNZ Inc. Executive Committee

PRESIDENT Lynette Lennox P (07) 839 8899 ext 23595 M (021) 846 385 E [email protected]

IMMEDIATE PAST PRESIDENT Kate Laidlow P (07) 348 1199 ext 8058 M (027) 839 6564 E [email protected]

SECRETARY Ellen Jones P (027) 225 5032 E [email protected]

TREASURER Fiona Williams P (07) 579 8517 E [email protected]

EDUCATOR Jenny Heretini M (021) 759 539 E [email protected]

WEBSITE Cheryl Phillips P (021) 152 1411 E [email protected]

EDITOR Ally Hale P (03) 687 1230 ext 260 E [email protected]

PRIVATE SECTOR Ally Hale P (03) 687 1230 ext 260 E [email protected]

Corporate Members of IVNNZ Inc.








